Kardigan, Inc. — Form 10-Q
Filed August 11, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 12/100
What the filing says
Kardigan, Inc. (CIK 0002123613), a pharmaceutical preparations company based in South San Francisco, CA, filed its Form 10-Q for the quarter ending June 30, 2026 on August 11, 2026. The filing contains standard quarterly disclosures including financial statements, certifications (Exhibits 31.1, 31.2, 32.1, 32.2), and XBRL data. No material transactions, financing, guidance changes, or operational events are disclosed in this header metadata.
Why this rating
Routine quarterly filing with no disclosed material events, transactions, or changes visible in metadata. Standard SEC compliance disclosure.
See more from August 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.